Extracellular vesicle biomarkers for complement dysfunction in schizophrenia.
Xue T, Liu W, Wang L, Shi Y, Hu Y, Yang J, Li G, Huang H, Cui D.
Brain. 2024 Mar 1;147(3):1075-1086. doi: 10.1093/brain/awad341.
PMID:37816260
Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, McGuire P, Do KQ, Arango C.
Development of machine-learning-driven signatures for diagnosing and monitoring therapeutic response in major depressive disorder using integrated immune cell profiles and plasma cytokines.
He S, Zhao F, Sun G, Shi Y, Xu T, Zhang Y, Li S, Zhang L, Chu X, Du C, Yang D, Zhang J, Ge C, Huang J, Xie Z, Li H.
Theranostics. 2024 Oct 28;14(18):7265-7280. doi: 10.7150/thno.102602. eCollection 2024.
PMID:39629120
What we know and what we don't know about the treatment of schizoaffective disorder.
Murru A, Pacchiarotti I, Nivoli AM, Grande I, Colom F, Vieta E.
Eur Neuropsychopharmacol. 2011 Sep;21(9):680-90. doi: 10.1016/j.euroneuro.2011.03.001. Epub 2011 May 12.
PMID:21565468
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrum.
Nguyen TD, Meijsen JJ, Sigström R, Kuja-Halkola R, Xiong Y, Harder A, Kowalec K, Pasman JA, Scarpa C, Hörbeck E, Jonsson L, Hägg S, Mullins N, O'Connell KS, Dalman C, Helenius D, Zetterberg R, Larsson H, Lichtenstein P, Andreassen OA, Werge T, Buil A, Landén M, Sullivan PF, Lu Y.
EBioMedicine. 2025 Feb;112:105576. doi: 10.1016/j.ebiom.2025.105576. Epub 2025 Jan 30.
PMID:39889373
[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y.
Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24.